Visus Therapeutics
0 followers
‌
Visus Therapeutics is a clinical-stage company in pursuit of developing the world’s first presbyopia-correcting eye drop with the potential to last at least eight hours.
Industries
Headquarters
Employees
Links
Org chart
Ben Bergo
CEO
Ben Bergo
Collapse
Rhett Schiffman
Chief Medical Officer & Head of R&D
David Toll
CFO
Lisa Simpson
VP, Clinical Operations & Compliance
Andy Firpo
VP, Information Technology
Patrick Hughes
VP, Pharmaceutical Development
Esther Cuno
VP, Human Resources
Robert Boxeth
Senior Quality Assurance Specialist
Kate Bishop
AVP, Legal & Intellectual Property
Dell Larned
Associate Director, Project Management
Dixie-Lee Shurland
Project Manager
Similar companies
Synthekine
3 followers
Forge Biologics
2 followers
Expansion Therapeutics
2 followers
Kyverna Therapeutics
5 followers
Caribou Biosciences
1 follower
Neuron23
1 follower
Slingshot Biosciences
1 follower
Odyssey Therapeutics
2 followers
Cellares
2 followers
Astria Therapeutics
1 follower
Thermo Fisher Scientific
149 followers
Discover companies